Expiry Of Warrants
Filed with BSE · · 1 page · English
Summary by 6ix AI
Vivo Bio Tech Ltd. has filed a disclosure regarding the expiry of outstanding convertible equity warrants allotted to promoters. The filing states that a significant number of these warrants have expired due to non-exercise within the specified tenure. Details of the warrants allotted and those that expired are included in the filing for record-keeping purposes.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Subject : Expiry of Outstanding Convertible Equity Warrants allotted to Promoters on 21st February, 2025 on 21 st February, 2025 Bhavish Vijayvargiya Company Secretary M.No.A77631
Earlier from Vivo Bio Tech
- Vivo Bio Tech Ltd. Press Release Jul 15 2026
- Announcement under Regulation 30 (LODR)-Newspaper Publication
- Vivo Bio Tech Ltd. Press Release Jul 14 2026
- Shareholder Meeting / Postal Ballot-Scrutinizer"s Report
- Vivo Bio Tech Ltd. Press Release Jul 13 2026
Later from Vivo Bio Tech
- Board Meeting Outcome for Outcome Of Board Meeting
- Announcement under Regulation 30 (LODR)-Change in Management
- Vivo Bio Tech Ltd. Press Release Aug 22 2026
- Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
- Vivo Bio Tech Ltd. Press Release Aug 24 2026
Follow Vivo Bio Tech into a list and get an email when it puts out news.
Follow Vivo Bio Tech